Drug ID: | NPD3593 |
Drug Name: | |
Molecular Formula: | C19H25N7O2 |
Canonical SMILES: | N#C[C@@H]1CCCN1C(=O)CNC(CN=C(c1cnc2n(c1)nc(c2)C)O)(C)C |
Standard InCHI: | InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1 |
Standard InCHIKey: | LDXYBEHACFJIEL-HNNXBMFYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002831 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 44513473 |
ChEBI | |
CAS Number |
Molecular Weight | 383.21 |
ALogP | -1.1912 |
MLogP | 2.56 |
XLogP | 0.55 |
HDA | 9 |
HBD | 2 |
Rotatable Bonds | 11 |
TPSA | 118.91 |
RO5 Violation | 0 |